Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.